50 likes | 225 Views
“OXiGENE, Inc. - Product Pipeline Review - 2014” Order report by calling ReportsnReports.com at 1 888 391 5441 OR send an email on sales@reportsandreports.com with “OXiGENE, Inc. - Product Pipeline Review - 2014” in subject line and your contact details.
E N D
OXiGENE, Inc. - Product Pipeline Review - 2014 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. Published: January 2014 Single User PDF: US$ 1500 Corporate User PDF: US$ 4500 © ReportsnReports.com / Contact sales@reportsandreports.com
OXiGENE, Inc. - Product Pipeline Review - 2014 Researcher’s pharmaceuticals report, "OXiGENE, Inc. Product Pipeline Review 2014" provides data on the OXiGENE, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Researcher’s proprietary databases, OXiGENE, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from OXiGENE, Inc. and industry-specific third party sources, put together by Researcher’s team. Inquiry Before Buying on this Report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=274891 . Scope OXiGENE, Inc. Brief OXiGENE, Inc. overview including business description, key information and facts, and its locations and subsidiaries. Review of current pipeline of OXiGENE, Inc. human therapeutic division. Overview of pipeline therapeutics across various therapy areas. Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com
OXiGENE, Inc. - Product Pipeline Review - 2014 Product profiles for late stage and clinical stage products of OXiGENE, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones. Recent updates of the OXiGENE, Inc.'s pipeline in the last quarter. Key discontinued and dormant projects. Latest news and deals relating to the products. Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx?name=274891 . Reasons to buy Evaluate OXiGENE, Inc.'s strategic position with total access to detailed information on its product pipeline. Assess the growth potential of OXiGENE, Inc. in its therapy areas of focus. Identify new drug targets and therapeutic classes in the OXiGENE, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. Exploit collaboration and partnership opportunities with OXiGENE, Inc.. Avoid Intellectual Property Rights related issues. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com
OXiGENE, Inc. - Product Pipeline Review - 2014 Table of Contents Table of Contents 2List of Tables 4List of Figures 4OXiGENE, Inc. Snapshot 5OXiGENE, Inc. Overview 5Key Information 5Key Facts 5OXiGENE, Inc. - Research and Development Overview 6Key Therapeutic Areas 6OXiGENE, Inc. - Pipeline Review 9Pipeline Products by Stage of Development 9Pipeline Products - Monotherapy 10OXiGENE, Inc. - Pipeline Products Glance 11OXiGENE, Inc. - Late Stage Pipeline Products 11Phase III Products/Combination Treatment Modalities 11OXiGENE, Inc. - Clinical Stage Pipeline Products 12Phase II Products/Combination Treatment Modalities 12Phase I Products/Combination Treatment Modalities 13OXiGENE, Inc. - Early Stage Pipeline Products 14 Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com
OXiGENE, Inc. - Product Pipeline Review - 2014 List of Tables OXiGENE, Inc., Key Information 5OXiGENE, Inc., Key Facts 5OXiGENE, Inc. - Pipeline by Indication, 2014 8OXiGENE, Inc. - Pipeline by Stage of Development, 2014 9OXiGENE, Inc. - Monotherapy Products in Pipeline, 2014 10OXiGENE, Inc. - Phase III, 2014 11OXiGENE, Inc. - Phase II, 2014 12OXiGENE, Inc. - Phase I, 2014 13OXiGENE, Inc. - Preclinical, 2014 14OXiGENE, Inc. - Discovery, 2014 15OXiGENE, Inc. - Unknown, 2014 16OXiGENE, Inc. - Pipeline by Therapeutic Class, 2014 26OXiGENE, Inc. - Pipeline by Target, 2014 27OXiGENE, Inc. - Pipeline by Route of Administration, 2014 28OXiGENE, Inc. - Pipeline by Molecule Type, 2014 29 Contactsales@reportsandreports.com/ Call +1 888 391 5441 for further information on “OXiGENE, Inc. - Product Pipeline Review - 2014” report OR for any other market research and intelligence needs you may have for your business. Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com with your contact details and questions if any. © ReportsnReports.com / Contact sales@reportsandreports.com